Abstract
Osteosarcoma is the most common type of primary malignant bone tumor. 18F-FDG PET/CT is useful for staging, detecting recurrence, monitoring response to neoadjuvant chemotherapy, and predicting prognosis. Here, we review the clinical aspects of osteosarcomamanagement and assess the role of 18F-FDG PET/CT, in particular with regard to pediatric and young adult patients.
Author supplied keywords
Cite
CITATION STYLE
APA
Oh, C., Bishop, M. W., Cho, S. Y., Im, H. J., & Shulkin, B. L. (2023). 18F-FDG PET/CT in the Management of Osteosarcoma. Journal of Nuclear Medicine, 64(6), 842–851. https://doi.org/10.2967/jnumed.123.265592
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free